Callan Capital’s Zogenix, Inc. ZGNX Stock Holding History

Callan Capital’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,250	Closed	-$17K	–	77
2015 Q2	$17K	Buy	+1,250	New	+$15.3K	﹤0.01%	70

Other funds holding ZGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Callan Capital's ZGNX Position: Q3 2015 in Review

Callan Capital sold out of Zogenix, Inc. (ZGNX) in Q3 2015, closing a stake of 1,250 shares — an estimated $17K sold.

Callan Capital first reported a position in ZGNX in Q2 2015 and held it in 1 quarter. The position peaked at $17K in Q2 2015. 99 funds tracked by Wall St. Rank hold ZGNX as of Q3 2015.

Callan Capital reported no remaining Zogenix, Inc. position as of Q3 2015 after selling out during the quarter.
Callan Capital sold 1,250 Zogenix, Inc. shares in Q3 2015, an estimated $17K.
Callan Capital first reported a position in Zogenix, Inc. in Q2 2015 and held it in 1 quarter.
Callan Capital's Zogenix, Inc. position peaked at $17K in Q2 2015.
99 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q3 2015.

Based on Callan Capital's 13F filing for Q3 2015, filed 10 Nov 2015.